The global embolic protection device market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of cardiovascular diseases and neurovascular diseases, which are major causes for embolism. The increasing number of patients with peripheral vascular disease is also driving the growth of this market.
Nitinol segment accounted for the largest share in 2018 and it is expected to maintain its dominance throughout the forecast period due to its high biocompatibility and low cost. Polyurethane segment accounted for a significant share in 2018 due to its low cost and high biocompatibility properties. Cardiovascular diseases segment dominated in 2018 due to their higher prevalence among all other applications segments, followed by neurovascular diseases segment which has been witnessing an increase in demand owing to increased awareness about stroke prevention among people suffering from cardiovascular disorders such as hypertension or diabetes mellitus type 2.
Some Of The Growth Factors Of This Market:
- The increasing number of patients with atrial fibrillation and other cardiac arrhythmias.
- The increasing number of patients with peripheral vascular disease.
- The increasing number of patients undergoing percutaneous coronary intervention (PCI) procedures.
- The increase in the use of embolic protection devices for the treatment of acute ischemic stroke.
- Increasing awareness about the benefits and risks associated with embolic protection devices.
Industry Growth Insights published a new data on “Embolic Protection Device Material Market”. The research report is titled “Embolic Protection Device Material Market research by Types (Nitinol, Polyurethane), By Applications (Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases), By Players/Companies Medtronic, Abbott Laboratories, Boston Scientific, Cordis (A Cardinal Health Company), Contego Medical, W. L. Gore & Associates, Silk Road Medical, Claret Medical, Allium Medical Solutions, Angioslide”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Embolic Protection Device Material Market Research Report
By Type
Nitinol, Polyurethane
By Application
Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases
By Companies
Medtronic, Abbott Laboratories, Boston Scientific, Cordis (A Cardinal Health Company), Contego Medical, W. L. Gore & Associates, Silk Road Medical, Claret Medical, Allium Medical Solutions, Angioslide
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Embolic Protection Device Material Market Report Segments:
The global Embolic Protection Device Material market is segmented on the basis of:
Types
Nitinol, Polyurethane
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott Laboratories
- Boston Scientific
- Cordis (A Cardinal Health Company)
- Contego Medical
- W. L. Gore & Associates
- Silk Road Medical
- Claret Medical
- Allium Medical Solutions
- Angioslide
Highlights of The Embolic Protection Device Material Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nitinol
- Polyurethane
- By Application:
- Cardiovascular Diseases
- Neurovascular Diseases
- Peripheral Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Embolic Protection Device Material Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Embolic protection devices are made from a variety of materials, including metal, plastic, and silicone.
Some of the major players in the embolic protection device material market are Medtronic, Abbott Laboratories, Boston Scientific, Cordis (A Cardinal Health Company), Contego Medical, W. L. Gore & Associates, Silk Road Medical, Claret Medical, Allium Medical Solutions, Angioslide.
The embolic protection device material market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Embolic Protection Device Material Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Embolic Protection Device Material Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Embolic Protection Device Material Market - Supply Chain
4.5. Global Embolic Protection Device Material Market Forecast
4.5.1. Embolic Protection Device Material Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Embolic Protection Device Material Market Size (000 Units) and Y-o-Y Growth
4.5.3. Embolic Protection Device Material Market Absolute $ Opportunity
5. Global Embolic Protection Device Material Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Embolic Protection Device Material Market Size and Volume Forecast by Type
5.3.1. Nitinol
5.3.2. Polyurethane
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Embolic Protection Device Material Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Embolic Protection Device Material Market Size and Volume Forecast by Application
6.3.1. Cardiovascular Diseases
6.3.2. Neurovascular Diseases
6.3.3. Peripheral Diseases
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Embolic Protection Device Material Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Embolic Protection Device Material Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Embolic Protection Device Material Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Embolic Protection Device Material Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Embolic Protection Device Material Demand Share Forecast, 2019-2029
9. North America Embolic Protection Device Material Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Embolic Protection Device Material Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Embolic Protection Device Material Market Size and Volume Forecast by Application
9.4.1. Cardiovascular Diseases
9.4.2. Neurovascular Diseases
9.4.3. Peripheral Diseases
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Embolic Protection Device Material Market Size and Volume Forecast by Type
9.7.1. Nitinol
9.7.2. Polyurethane
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Embolic Protection Device Material Demand Share Forecast, 2019-2029
10. Latin America Embolic Protection Device Material Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Embolic Protection Device Material Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Embolic Protection Device Material Market Size and Volume Forecast by Application
10.4.1. Cardiovascular Diseases
10.4.2. Neurovascular Diseases
10.4.3. Peripheral Diseases
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Embolic Protection Device Material Market Size and Volume Forecast by Type
10.7.1. Nitinol
10.7.2. Polyurethane
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Embolic Protection Device Material Demand Share Forecast, 2019-2029
11. Europe Embolic Protection Device Material Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Embolic Protection Device Material Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Embolic Protection Device Material Market Size and Volume Forecast by Application
11.4.1. Cardiovascular Diseases
11.4.2. Neurovascular Diseases
11.4.3. Peripheral Diseases
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Embolic Protection Device Material Market Size and Volume Forecast by Type
11.7.1. Nitinol
11.7.2. Polyurethane
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Embolic Protection Device Material Demand Share, 2019-2029
12. Asia Pacific Embolic Protection Device Material Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Embolic Protection Device Material Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Embolic Protection Device Material Market Size and Volume Forecast by Application
12.4.1. Cardiovascular Diseases
12.4.2. Neurovascular Diseases
12.4.3. Peripheral Diseases
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Embolic Protection Device Material Market Size and Volume Forecast by Type
12.7.1. Nitinol
12.7.2. Polyurethane
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Embolic Protection Device Material Demand Share, 2019-2029
13. Middle East & Africa Embolic Protection Device Material Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Embolic Protection Device Material Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Embolic Protection Device Material Market Size and Volume Forecast by Application
13.4.1. Cardiovascular Diseases
13.4.2. Neurovascular Diseases
13.4.3. Peripheral Diseases
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Embolic Protection Device Material Market Size and Volume Forecast by Type
13.7.1. Nitinol
13.7.2. Polyurethane
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Embolic Protection Device Material Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Embolic Protection Device Material Market: Market Share Analysis
14.2. Embolic Protection Device Material Distributors and Customers
14.3. Embolic Protection Device Material Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cordis (A Cardinal Health Company)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Contego Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. W. L. Gore & Associates
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Silk Road Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Claret Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Allium Medical Solutions
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Angioslide
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
